Real-time enrollment status for this advanced cancer clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 3:03 PM UTC
| NCT Number | NCT04752826 |
| Recruiting Status | Recruiting |
| Condition | Advanced Cancer |
| Phase | PHASE1 |
| Target Enrollment | 250 participants |
| Active Locations | 3 sites in the US |
| Sponsor | BioInvent International AB |
| Last Updated on CT.gov | September 18, 2026 (Sep 18, 2026) |
As of October 19, 2026: Clinical trial NCT04752826 is currently recruiting participants. This phase1 study for advanced cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by BioInvent International AB. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04752826 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04752826 was last updated Sep 18, 2026 (September 18, 2026). HelloStudys verifies this status automatically.